Powder Absorbable Hemostat Market Report 2026

Powder Absorbable Hemostat Market Overview

• Powder Absorbable Hemostat market size has reached to $2.48 billion in 2025 • Expected to grow to $3.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.1% • Growth Driver: The Increasing Number Of Surgeries Is Fueling The Growth Of The Market Due To Rising Demand For Effective Bleeding Control Solutions • Market Trend: Advancements In Passive Absorbable Hemostatic Powders For Improved Surgical Bleeding Control • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Powder Absorbable Hemostat Market?

An absorbable powder hemostat is a sterile, bioresorbable substance designed to stop bleeding during surgery. It is made from plant- or animal-based polysaccharides, helps to quickly absorb blood, and aids in forming clots. Its powder form allows easy application to irregular or hard-to-access surgical sites. Its primary function is to provide rapid hemostasis and minimize bleeding-related surgical risks. The main product types of powder absorbable hemostats are collagen-based hemostats, gelatin-based hemostats, cellulose-based hemostats, and combination hemostats. Collagen-based powders, derived from bovine or porcine tissue, promote rapid clotting by activating platelets and are widely used in surgical settings for effective bleeding control. It is formulated in various formulations, such as powder formulations, ready-to-use formulations, pre-mixed formulations, and custom formulations, and is distributed through several distribution channels, including direct sales, distributors, online sales platforms, pharmacies, and others. It is applicable in various applications such as surgical procedures, trauma care, orthopedic surgeries, and cardiovascular surgeries, and is used by various end-users, including hospitals, ambulatory surgical centers, specialty clinics, outpatient surgery facilities, and others.

What Is The Powder Absorbable Hemostat Market Growth Forecast?

The powder absorbable hemostat market size is expected to see strong growth in the next few years. It will grow to $3.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to innovations in powder hemostat formulations, growth in minimally invasive surgeries, expansion of ambulatory surgical centers, increasing geriatric population, rising healthcare expenditure. Major trends in the forecast period include minimally invasive surgical techniques, rapid hemostasis solutions, biocompatible & bioresorbable materials, customizable powder hemostat formulations, growth in ambulatory & outpatient surgical procedures.

Global Powder Absorbable Hemostat Market Segmentation

1) By Product Type: Collagen-Based Hemostats, Gelatin-Based Hemostats, Cellulose-Based Hemostats, Combination Hemostats 2) By Formulation: Powder Formulations, Ready-To-Use Formulations, Pre-Mixed Formulations, Custom Formulations 3) By Distribution Channel: Direct Sales, Distributors 4) By Application: Surgical Procedures, Trauma Care, Orthopedic Surgeries, Cardiovascular Surgeries 5) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Outpatient Surgery Facilities, Other End-Users Subsegments: 1) By Collagen-Based Hemostats: Bovine Collagen Hemostats, Porcine Collagen Hemostats, Synthetic Collagen Hemostats 2) By Gelatin-Based Hemostats: Porcine Gelatin Hemostats, Bovine Gelatin Hemostats, Recombinant Gelatin Hemostats 3) By Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Hemostats, Oxidized Cellulose Hemostats, Carboxymethyl Cellulose Hemostats 4) By Combination Hemostats: Collagen + Gelatin Combination Hemostats, Collagen + Cellulose Combination Hemostats, Gelatin + Cellulose Combination Hemostats, Multi-component (Collagen + Gelatin + Cellulose) Hemostats

What Is The Driver Of The Powder Absorbable Hemostat Market?

The increasing number of surgeries is expected to propel the growth of the powder absorbable hemostat market going forward. Surgeries are medical interventions that use hands-on or instrument-based methods to address injuries or illnesses or enhance physical function. The rise in surgeries is driven by the growing burden of chronic diseases that often necessitate surgical treatment for proper management. The rising volume of surgeries fuels the demand for efficient bleeding control, boosting the use of powder absorbable hemostats. Their fast-acting, precise hemostasis is especially valuable in delicate or minimally invasive procedures, improving patient outcomes. For instance, in March 2023, according to the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, 31,057 cosmetic surgeries took place in 2022 in the UK, marking a notable 102% increase from the previous year. Therefore, the increasing number of surgeries is driving the growth of the powder absorbable hemostat industry.

Key Players In The Global Powder Absorbable Hemostat Market

Major companies operating in the powder absorbable hemostat market are Johnson & Johnson, Baxter International, Integra LifeSciences Corporation, Hangzhou Singclean Medical Products Co. Ltd, Gelita Medical GmbH, Algan Grup Sağlık Hizmetleri, Ferrosan Medical Devices, Hemostasis LLC, CuraMedical B.V., BioCer Entwicklungs GmbH, Medcura Inc., Starch Medical Inc., Aegis Lifesciences, Hemostat Medical GmbH, B. Braun Melsungen AG, Pfizer Hospital Products, Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Anika Therapeutics Inc., Teleflex Medical, Ethicon Biosurgery, Z Medica LLC

Global Powder Absorbable Hemostat Market Trends and Insights

Major companies operating in the powder absorbable hemostat market are focusing on developing advanced products, such as plant-based polysaccharide absorbable hemostat powder, to enhance clotting efficiency and improve safety in surgical applications. Plant-based polysaccharide absorbable hemostat powder is made from refined natural starch and works by quickly absorbing blood to trigger clotting. It is completely bioresorbable, eliminating the need for removal after application. For instance, in July 2023, Baxter International Inc., a US-based healthcare company, introduced PERCLOT, a starch-derived passive absorbable hemostatic powder, in the U.S. It is designed for patients with intact coagulation to control mild bleeding during surgery. Its granules rapidly absorb water, forming a gelled adhesive matrix that creates a mechanical barrier to bleeding and promotes the accumulation of platelets, red blood cells, and coagulation proteins. This product complements Baxter’s hemostat portfolio by helping reduce blood transfusions and complications while lowering overall care costs.

What Are Latest Mergers And Acquisitions In The Powder Absorbable Hemostat Market?

In April 2025, Olympus Canada Inc., a Canada-based provider of medical technology solutions, partnered with EndoClot Plus, Inc., to advance gastrointestinal (GI) care through innovative endoscopic solutions. This partnership aims to strengthen Olympus’ GI portfolio by delivering advanced hemostatic technologies for improved clinical outcomes in EMR and ESD procedures across Canada. EndoClot Plus, Inc. is a US-based manufacturer of the powder absorbable hemostat system.

Regional Outlook

North America was the largest region in the powder absorbable hemostat market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Powder Absorbable Hemostat Market?

The powder absorbable hemostat market consists of sales of chitosan-based hemostats, kaolin-based hemostats, and oxidized regenerated cellulose (ORC) powders. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.